Hengehold Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $353K | Buy |
3,854
+3
| +0.1% | +$262 | 0.03% | 170 |
|
|
2026
Q1 | $328K | Hold |
3,851
| – | – | 0.03% | 166 |
|
|
2025
Q4 | $304K | Hold |
3,851
| – | – | 0.03% | 181 |
|
|
2025
Q3 | $308K | Buy |
3,851
+22
| +0.6% | +$1.88K | 0.03% | 178 |
|
|
2025
Q2 | $348K | Hold |
3,829
| – | – | 0.03% | 160 |
|
|
2025
Q1 | $359K | Hold |
3,829
| – | – | 0.03% | 154 |
|
|
2024
Q4 | $348K | Hold |
3,829
| – | – | 0.03% | 160 |
|
|
2024
Q3 | $397K | Sell |
3,829
-1
| -0% | -$102 | 0.04% | 130 |
|
|
2024
Q2 | $372K | Buy |
3,830
+200
| +6% | +$18.4K | 0.04% | 131 |
|
|
2024
Q1 | $327K | Buy |
3,630
+400
| +12% | +$33.9K | 0.03% | 144 |
|
|
2023
Q4 | $257K | Hold |
3,230
| – | – | 0.03% | 152 |
|
|
2023
Q3 | $230K | Hold |
3,230
| – | – | 0.03% | 154 |
|
|
2023
Q2 | $249K | Hold |
3,230
| – | – | 0.03% | 149 |
|
|
2023
Q1 | $243K | Hold |
3,230
| – | – | 0.03% | 147 |
|
|
2022
Q4 | $254K | Buy |
3,230
+8
| +0.2% | +$600 | 0.04% | 147 |
|
|
2022
Q3 | $226K | Hold |
3,222
| – | – | 0.03% | 139 |
|
|
2022
Q2 | $258K | Hold |
3,222
| – | – | 0.04% | 133 |
|
|
2022
Q1 | $244K | Hold |
3,222
| – | – | 0.03% | 142 |
|
|
2021
Q4 | $275K | Hold |
3,222
| – | – | 0.03% | 139 |
|
|
2021
Q3 | $244K | Hold |
3,222
| – | – | 0.03% | 142 |
|
|
2021
Q2 | $262K | Hold |
3,222
| – | – | 0.03% | 131 |
|
|
2021
Q1 | $254K | Buy |
3,222
+21
| +0.7% | +$1.65K | 0.04% | 126 |
|
|
2020
Q4 | $274K | Hold |
3,201
| – | – | 0.04% | 117 |
|
|
2020
Q3 | $247K | Hold |
3,201
| – | – | 0.04% | 116 |
|
|
2020
Q2 | $235K | Hold |
3,201
| – | – | 0.04% | 112 |
|
|
2020
Q1 | $212K | Buy |
3,201
+20
| +0.6% | +$1.41K | 0.05% | 108 |
|
|
2019
Q4 | $219K | Hold |
3,181
| – | – | 0.04% | 131 |
|
|
2019
Q3 | $234K | Sell |
3,181
-150
| -5% | -$10.9K | 0.04% | 118 |
|
|
2019
Q2 | $239K | Hold |
3,331
| – | – | 0.05% | 113 |
|
|
2019
Q1 | $228K | Buy |
+3,331
| New | +$215K | 0.05% | 114 |
|
|
2018
Q4 | – | Sell |
-3,381
| Closed | -$226K | – | 117 |
|
|
2018
Q3 | $226K | Hold |
3,381
| – | – | 0.06% | 112 |
|
|
2018
Q2 | $219K | Hold |
3,381
| – | – | 0.06% | 107 |
|
|
2018
Q1 | $242K | Hold |
3,381
| – | – | 0.06% | 101 |
|
|
2017
Q4 | $255K | Sell |
3,381
-333
| -9% | -$24.3K | 0.07% | 99 |
|
|
2017
Q3 | $271K | Buy |
3,714
+333
| +10% | +$24K | 0.07% | 92 |
|
|
2017
Q2 | $251K | Hold |
3,381
| – | – | 0.07% | 95 |
|
|
2017
Q1 | $247K | Hold |
3,381
| – | – | 0.07% | 97 |
|
|
2016
Q4 | $221K | Sell |
3,381
-270
| -7% | -$18.5K | 0.07% | 100 |
|
|
2016
Q3 | $271K | Buy |
3,651
+420
| +13% | +$31K | 0.09% | 81 |
|
|
2016
Q2 | $237K | Hold |
3,231
| – | – | 0.08% | 83 |
|
|
2016
Q1 | $228K | Hold |
3,231
| – | – | 0.07% | 83 |
|
|
2015
Q4 | $215K | Hold |
3,231
| – | – | 0.08% | 81 |
|
|
2015
Q3 | $205K | Buy |
+3,231
| New | +$211K | 0.09% | 78 |
|
Other funds holding CL
Hengehold Capital Management's CL Position: Q2 2026 in Review
Hengehold Capital Management increased its Colgate-Palmolive (CL) stake by 0.08% in Q2 2026, buying an estimated $262 and bringing the position to 3,854 shares worth $353K. The position accounts for 0.03% of the portfolio, ranked #170.
Hengehold Capital Management first reported a position in CL in Q3 2015 and has held it in 43 quarters since. The position peaked at $397K in Q3 2024. 1,280 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Hengehold Capital Management held 3,854 shares of Colgate-Palmolive worth $353K as of Q2 2026.
- Hengehold Capital Management bought 3 Colgate-Palmolive shares in Q2 2026, an estimated $262.
- Colgate-Palmolive made up 0.03% of Hengehold Capital Management's portfolio in Q2 2026, its #170 holding.
- Hengehold Capital Management first reported a position in Colgate-Palmolive in Q3 2015 and has held it in 43 quarters since.
- Hengehold Capital Management's Colgate-Palmolive position peaked at $397K in Q3 2024.
- 1,280 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.